Exact Sciences Corporation (EXAS)
|52 Week Range||43.9-100.77|
|1y Target Est||-|
|DCF Unlevered||EXAS DCF ->|
|DCF Levered||EXAS LDCF ->|
|Debt / Equity||153.60%||Buy|
Upgrades & Downgrades
Latest EXAS news
3 Stocks at the Forefront of Personalized Medicine Trend
5 December 2023
In the rapidly evolving healthcare sector, the idea of personalized medicine stocks stands out, revolutionizing patient care by tailoring treatments with their individual genetic profiles. These stock...
The 3 Best Digital Health Stocks for Personalized Medicine
25 November 2023
If you're searching for digital health stocks to add to your portfolio, look no further. Technological innovation is leading to the increased digitalization and personalization of healthcare.
3 Biotech Stocks With Big-Time Breakthrough Potential
20 November 2023
In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. These biotech companies are not only doing the job, b...
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
20 November 2023
We have narrowed our search to five biotech stocks with strong potential for 2024. These are: LEGN, BGNE, GILD, EXAS, SRPT.
3 Stocks to Love Despite All of the Wall Street Hate
14 November 2023
Multi-billionaire investor Ken Fisher wrote recently that the stocks of relatively small companies tend to be very unpopular with the Street during the early phase of bull markets. Therefore, Fisher's...
Exact Sciences (EXAS) Just Overtook the 20-Day Moving Average
6 November 2023
From a technical perspective, Exact Sciences (EXAS) is looking like an interesting pick, as it just reached a key level of support. EXAS recently overtook the 20-day moving average, and this suggests ...
Exact Sciences (EXAS) Q3 Earnings Beat, Gross Margin Rises
2 November 2023
Exact Sciences' (EXAS) Screening revenue upside is primarily attributable to broad-based momentum in Cologuard adoption.
Exact Sciences to participate in November investor conferences
1 November 2023
MADISON, Wis. , Nov. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate ...
3 Comeback Stocks to Buy Before They Soar Again in 2024
23 October 2023
Many investors are probably upset that the yields of the 10-year treasury bonds are trading around 5%. It's true that higher bond yields do increases companies' borrowing costs and make stocks less at...